Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Tofacitinib was found to be a safe and effective treatment for hair regrowth in patients with alopecia areata.

Tofacitinib effectively improved severe skin symptoms in a patient with Hypohidrotic Ectodermal Dysplasia.

IL-4 and IL-13 might play a role in a type of hair loss similar to alopecia areata.

Oral and topical tofacitinib can help regrow hair in people with severe alopecia areata.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

Baricitinib was more effective than a placebo in regrowing hair in adults with alopecia areata after 36 weeks.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

New treatments for hair loss are emerging, and doctors need to learn how to use them effectively.

The study created 3D-printed pills that effectively release a hair loss treatment drug over 24 hours.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Increasing the dose of baricitinib to 4 mg helps more patients with severe alopecia areata regrow hair.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Expanded CD8+ T cells are linked to Alopecia Areata and may cause relapse after treatment.

Fzd2 is important for skin and hair development through various signaling ways.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.

rwSALT provides precise hair regrowth measurement from scalp photos.

rwSALT accurately measures hair regrowth in alopecia areata using scalp photos.

Tofacitinib helped a patient regrow hair after 40 years of total hair loss.

Upadacitinib improves life quality for Alopecia Areata patients without worsening skin issues.

Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.

Deuruxolitinib is approved to treat severe alopecia areata in adults.

Chronic refractory alopecia areata has more skin-resident memory T cells, and JAK inhibitors may help reduce them.

Baricitinib effectively regrows scalp hair in most people with severe alopecia areata.

Baricitinib significantly regrows hair in nasal, genital, and beard areas for severe alopecia areata.